儿童会厌固定术:适应证、技术、结局与并发症的范围综述
结果显示呼吸改善一致、吞咽功能多保留或改善、并发症与复发率低,多数单次手术成功;但证据受限于小样本回顾性研究,需前瞻性标准化研究。
要点
- 会厌固定术对儿童会厌脱垂安全有效,呼吸改善一致且并发症与复发率低。
- 药物诱导睡眠内镜(DISE)将适应证扩展至睡眠状态依赖性会厌阻塞。
- 证据受限于小样本回顾性系列,需前瞻性标准化DISE方案与结局指标。
核心结论
- 会厌固定术在多种临床情境和技术下对儿童会厌脱垂报告为安全有效。
- DISE已将适应证扩展至睡眠状态依赖性会厌阻塞。
研究设计与样本
- 范围综述遵循PRISMA-ScR指南,方案在数据提取前注册于OSF。
- 检索PubMed/MEDLINE、Scopus、Web of Science和Google Scholar,时间1980年1月至2026年5月,限英法文并手工检索参考文献。
- 两名评价者独立筛选和提取数据,结果进行描述性综合。
主要发现
- 手术方式包括内镜CO2激光或电灼辅助舌会厌固定术、经口缝线会厌固定术、经颈外固定和机器人辅助会厌固定术。
- 适应证涵盖经典III型喉软化、会厌脱垂合并气管造瘘依赖或综合征性气道疾病,以及 increasingly DISE确认的难治性OSA儿童会厌阻塞。
- 呼吸改善一致报告,吞咽功能多保留或改善,并发症和复发率低,多数病例单次手术成功。
临床怎么用
- 会厌固定术可用于儿童会厌脱垂相关气道阻塞,包括DISE确认的睡眠状态依赖性阻塞。
- 术前应结合DISE评估会厌阻塞与睡眠状态的关联以指导适应证选择。
局限性
- 证据受限于小样本回顾性系列研究。
- 需前瞻性研究采用标准化DISE方案、结局指标和更长随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To map and synthesize the evidence on epiglottopexy in pediatric patients with laryngomalacia, epiglottic prolapse, and obstructive sleep apnea (OSA) with attention to indications, techniques, outcomes, complications, and evidence gaps. DATA SOURCES: PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar were searched from January 1980 to May 2026 for English- and French-language studies, supplemented by hand-searching of reference lists. REVIEW METHODS: This scoping review followed PRISMA-ScR guidelines. The review protocol was registered on OSF prior to data extraction. Eligible studies were original reports of pediatric patients (< 18 years) who underwent epiglottopexy for any indication. Two reviewers independently screened records and extracted data; findings were synthesized descriptively. RESULTS: Twenty-four studies (371 patients) published between 1987 and 2026 met inclusion criteria, comprising case reports, case series, and retrospective cohorts from 10 countries. Surgical approaches included endoscopic CO2 laser or cautery-assisted glossoepiglottopexy, transoral suture-based epiglottopexy, transcervical external fixation, and robot-assisted epiglottopexy. Indications spanned classic Type III laryngomalacia, epiglottic prolapse complicating tracheostomy-dependent or syndromic airway disease, and increasingly, drug-induced sleep endoscopy (DISE)-confirmed epiglottic obstruction in children with refractory OSA. Respiratory improvement was consistently reported, swallowing function was largely preserved or improved, and complication and recurrence rates were low, with single-procedure success in most cases. CONCLUSION: Epiglottopexy is reported to be safe and effective for pediatric epiglottic prolapse across diverse clinical contexts and techniques. DISE has expanded its indications to sleep-state-dependent epiglottic obstruction. Evidence remains limited by small, retrospective series; prospective studies with standardized DISE protocols, outcome measures, and longer follow-up are needed. LEVEL OF EVIDENCE: N/A.
引用
- Estephan K, Bergeron M. Pediatric Epiglottopexy: A Scoping Review of Indications, Techniques, Outcomes, and Complications. Laryngoscope. 2026. PMID: 42732995. doi:10.1002/lary.70917
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。